BUSCHARD, KARSTEN,FUNDA, DAVID,FUNDOVA, PETRA,HANSEN, AXEL
申请号：
AT08803975
公开号：
AT542540T
申请日:
2008.09.10
申请国别(地区):
AT
年份:
2012
代理人:
摘要：
The invention herein is related to intranasal or other mucosal administration of gliadin, or parts thereof, to prevent the development of type 1 diabetes. This environmental antigen, which may have etiological role in the development of diabetes in genetically predisposed individuals, has been successfully applied in the prevention of disease.
